OTC · Drug Manufacturers - Specialty & Generic

Biofrontera AG (BFFTF) Stock

$0.33 -95.24% OTC: BFFTF Healthcare

Biofrontera AG operates as a biopharmaceutical enterprise, dedicated to the exploration, evolution, and commercialization of dermatological therapies. Its flagship offerings, Ameluz and the BF-RhodoLED lamp, are utilized for treating mild to moderate actinic keratoses on the face and scalp, managing field cancerization, and addressing life-threatening squamous cell carcinoma.

Valuation

MetricValue
Price$0.33
Market Cap$19.35M
P/E Ratio-0.97
P/B Ratio2.10
P/S Ratio0.32
EPS (TTM)$-13.02
52-Week High$22.68
52-Week Low$0.33
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-476.72%
ROA-44.72%
ROCE-64.33%
Gross Margin82.79%
Operating Margin-20.64%
Net Margin-25.66%
Debt/Equity1.27
Current Ratio1.20

Annual Financials (USD)

Metric20192020202120222023
Revenue$26.0M$19.0M$24.0M$29.0M$34.0M
Operating Profit$-15.0M$-8.0M$-26.0M$-22.0M$-23.0M
Net Profit$-11.0M$-11.0M$-38.0M$-1.0M$-20.0M
EPS$-18.09$-18.94$-44.10$-0.61$-13.02
Op Margin-57.0%-44.2%-107.3%-78.0%-66.6%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$29.0M$24.0M$53.0M$51.0M$28.0M
Total Liabilities$59.0M$18.0M$42.0M$27.0M$23.0M
Cash$7.0M$8.0M$25.0M$17.0M$1.0M
Borrowings$38.0M$0$0$1.0M$6.0M

Latest News

BlackRock AUM hits $15.3tn in Q2 2026 Private Banker International · Jul 16, 2026 DBS sets 2030 wealth AUM goal above S$1tn – report Private Banker International · Jul 16, 2026 State Street Q2 Earnings, Revenue Rise MT Newswires · Jul 16, 2026 RBC Raises Price Target on ASML Holding to $2,100 From $2,000, Keeps Outperform Rating MT Newswires · Jul 16, 2026 Dow Jones Futures Rise But AI Woes Continue; Taiwan Semi, GE, UnitedHealth Are Key Earnings Movers Investor's Business Daily · Jul 16, 2026

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-38.0M$-12.0M$-27.0M$-16.0M$-25.0M
Investing Cash Flow$25.0M$0$0$-10.0M$1.0M
Financing Cash Flow$3.0M$4.0M$13.0M$5.0M$8.0M
Net Cash Flow$4.0M$1.0M$16.0M$-7.0M$-16.0M
Free Cash Flow$-38.0M$-12.0M$-27.0M$-16.0M$-25.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.03
EV / EBITDA-1.54
FCF Yield-66.77%
Quick Ratio1.09
Interest Coverage-40.36
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Biofrontera AG

Biofrontera AG operates as a biopharmaceutical enterprise, dedicated to the exploration, evolution, and commercialization of dermatological therapies. Its flagship offerings, Ameluz and the BF-RhodoLED lamp, are utilized for treating mild to moderate actinic keratoses on the face and scalp, managing field cancerization, and addressing life-threatening squamous cell carcinoma. The company is also advancing RhodoLED XL, intended for extensive interspersed lesions, and provides Belixos, an innovative cosmetic product designed for sensitive and irritated skin. Furthermore, Biofrontera develops Xepi, an agent targeting infections from antibiotic-resistant bacteria. The company primarily markets its solutions across the United States, Europe, and Israel, and maintains a collaborative and partnership agreement with Maruho Co., Ltd. Founded in 1997, Biofrontera AG's corporate headquarters are situated in Leverkusen, Germany.

Biofrontera AG is headquartered in DE.

Biofrontera AG (BFFTF) stock trades at $0.33 with a market capitalization of $19.35M. The stock is valued at a price-to-earnings (P/E) ratio of -0.97, price-to-book of 2.10, price-to-sales of 0.32. Over the past 52 weeks the stock has ranged between $0.33 and $22.68, and currently trades 98.5% below its 52-week high.

On profitability, Biofrontera AG generates a return on equity (ROE) of -476.72%, return on capital employed of -64.33%, an operating margin of -20.64%, a net profit margin of -25.66%.

Official website: www.biofrontera.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides